Basel Medical GroupBMGL

13F holders, Q3 2025 (September 30)
10holders +4
7new positions
3sold out
1famous investor
$1.81avg. 13F price*

At the end of Q3 2025, 10 institutions reported holding Basel Medical Group Ltd. (BMGL) in their 13F filings, up 4 from Q2 2025. 7 opened new positions and 3 sold out. The largest holders were Citadel Advisors ($169K), Morgan Stanley ($135K) and Marex Group Ltd ($105K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Basel Medical Group Ltd.
CUSIP
G0864B103
Latest filing quarter
Q1 2026

History

Number of 13F holders

0246810 Q2 2025: 6Q2 2025Q3 2025: 10Q3 2025Q4 2025: 10Q4 2025Q1 2026: 4Q1 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions7$347K
Exits3$157K

All 13F filers, Q2 2025 → Q3 2025: 253,776 shares bought and 88,594 shares sold, net +165,182 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Citadel Advisors 0.00% New 92,997 $169K
Morgan Stanley 0.00% New 74,292 $135K
Marex Group Ltd 0.00% Add +323.1% 58,913 $105K
Virtu Financial LLC 0.00% Add +108.8% 33,786 $61K
Vanguard Personalized Indexing Management, LLC 0.00% New 22,107 $40K
UBS Group AG 0.00% Add +4.5% 5,899 $11K
WealthCollab, LLC 0.00% New 953 $2K
EverSource Wealth Advisors, LLC 0.00% New 277 $504
Bell Investment Advisors, Inc 0.00% New 248 $452
Coston, McIsaac & Partners 0.00% New 50 $0

"% of holder's portfolio" is BMGL's weight in each manager's 13F, not the share of Basel Medical Group Ltd. the manager owns.